Kowa: Confirmed antiviral effect of ivermectin on Omicron strain:
-Phase 3 clinical trial of ivermectin-
[Tokyo 31st Reuters]
Kowa: (Nagoya)
January 31st,
As a treatment for new coronavirus infections
We are conducting a phase 3 clinical trial of “ivermectin”.
Ivermectin
Phase 3 clinical trial
From joint research (non-clinical trial) with Kitasato University
Even for Omicron strains
Equivalent to mutant strains such as Delta strains,
It was confirmed that it has an antiviral effect.
“Ivermectin”
Professor Satoshi Omura of Kitasato University, who won the Nobel Prize in Physiology or Medicine in 2015.
A medicine developed by Satoshi Omura, a special honorary professor.
It is used mainly in African countries as a therapeutic agent for parasitic infections.
Currently, clinical trials are being conducted as a new type of corona treatment.
Reuters
https://jp.reuters.com/article/kowa-ivermectin-idJPKBN2K50B7
Confirmed antiviral effect of Kowa ivermectin on “Omicron strain”